Detalhe da pesquisa
1.
Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease.
Annu Rev Pharmacol Toxicol
; 64: 359-386, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37708433
2.
Default Mode Network Modulation by Psychedelics: A Systematic Review.
Int J Neuropsychopharmacol
; 26(3): 155-188, 2023 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36272145
3.
Hypocretins (orexins): The ultimate translational neuropeptides.
J Intern Med
; 291(5): 533-556, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35043499
4.
Selective NaV1.1 activation rescues Dravet syndrome mice from seizures and premature death.
Proc Natl Acad Sci U S A
; 115(34): E8077-E8085, 2018 08 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30076230
5.
Novel alterations in corneal neuroimmune phenotypes in mice with central nervous system tauopathy.
J Neuroinflammation
; 17(1): 136, 2020 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32345316
6.
Hypnotics with novel modes of action.
Br J Clin Pharmacol
; 86(2): 244-249, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31756268
7.
Discovery of 1H-pyrazolo[3,4-b]pyridines as potent dual orexin receptor antagonists (DORAs).
Bioorg Med Chem Lett
; 25(23): 5555-60, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26522950
8.
Enhanced proteolytic clearance of plasma Aß by peripherally administered neprilysin does not result in reduced levels of brain Aß in mice.
J Neurosci
; 33(6): 2457-64, 2013 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23392674
9.
Orexin 2 receptor antagonism sex-dependently improves sleep/wakefulness and cognitive performance in tau transgenic mice.
Br J Pharmacol
; 181(1): 87-106, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37553894
10.
Altered EEG power spectrum, but not sleep-wake architecture, in HCN1 knockout mice.
Behav Brain Res
; 437: 114105, 2023 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36089097
11.
The second-generation active Aß immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects.
J Neurosci
; 31(25): 9323-31, 2011 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-21697382
12.
Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation.
Proc Natl Acad Sci U S A
; 106(31): 12926-31, 2009 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-19622727
13.
Losing sleep with age.
Science
; 375(6583): 816-817, 2022 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35201892
14.
Orexin Signaling: A Complex, Multifaceted Process.
Front Cell Neurosci
; 16: 812359, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35496914
15.
Differential sleep/wake response and sex differences following acute suvorexant, MK-1064 and zolpidem administration in the rTg4510 mouse model of tauopathy.
Br J Pharmacol
; 179(13): 3403-3417, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35112344
16.
Manipulation of rapid eye movement sleep via orexin and GABAA receptor modulators differentially affects fear extinction in mice: effect of stable versus disrupted circadian rhythm.
Sleep
; 44(9)2021 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33720375
17.
Decreased Orexin Receptor 1 mRNA Expression in the Locus Coeruleus in Both Tau Transgenic rTg4510 and Tau Knockout Mice and Accompanying Ascending Arousal System Tau Invasion in rTg4510.
J Alzheimers Dis
; 79(2): 693-708, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33361602
18.
Synthesis of the Potent, Selective, and Efficacious ß-Secretase (BACE1) Inhibitor NB-360.
J Med Chem
; 64(8): 4677-4696, 2021 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33844524
19.
Discovery of Umibecestat (CNP520): A Potent, Selective, and Efficacious ß-Secretase (BACE1) Inhibitor for the Prevention of Alzheimer's Disease.
J Med Chem
; 64(20): 15262-15279, 2021 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34648711
20.
Reward motivation and cognitive flexibility in tau null-mutation mice.
Neurobiol Aging
; 100: 106-117, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33524848